Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) EBITDA (2016 - 2025)

Historic EBITDA for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$26.9 million.

  • SRx Health Solutions' EBITDA fell 56516.93% to -$26.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$20.6 million, marking a year-over-year decrease of 7166.51%. This contributed to the annual value of $4.2 million for FY2024, which is 11979.32% up from last year.
  • SRx Health Solutions' EBITDA amounted to -$26.9 million in Q2 2025, which was down 56516.93% from -$1.1 million recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' EBITDA ranged from a high of $8.5 million in Q4 2024 and a low of -$26.9 million during Q2 2025
  • For the 5-year period, SRx Health Solutions' EBITDA averaged around -$5.3 million, with its median value being -$3.6 million (2022).
  • Per our database at Business Quant, SRx Health Solutions' EBITDA soared by 32390.72% in 2024 and then plummeted by 56516.93% in 2025.
  • Over the past 5 years, SRx Health Solutions' EBITDA (Quarter) stood at -$5.0 million in 2021, then crashed by 385.37% to -$24.2 million in 2022, then skyrocketed by 47.33% to -$12.7 million in 2023, then surged by 166.89% to $8.5 million in 2024, then tumbled by 416.38% to -$26.9 million in 2025.
  • Its last three reported values are -$26.9 million in Q2 2025, -$1.1 million for Q1 2025, and $8.5 million during Q4 2024.